SIRT7 and breast carcinoma: Consistently, a negative correlation between SIRT7 and TGF-β pathways was found in SIRT7 KD BT549 cells, a triple negative and metastatic site-derived breast cancer cell line, as determined by gene set enrichment analysis (GSEA)33 (Fig. 3a).